Quotient Awarded Group Purchasing Contract with Premier, Inc. for Blood Bank Reagents
JERSEY, Channel Islands, April 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that its U.S. subsidiary, Quotient Biodiagnostics, Inc. (“Quotient Biodiagnostics”), has signed a national …